GOLM2 and neoplasm: Similar stratification was performed on tumor mass spectrometry data, generating CASC4 proteinhigh and CASC4 proteinlow populations; the CASC4 proteinhigh population exhibited significantly worse progression free survival outcomes (14.76 months vs. 18.05 months, Logrank p = 0.0216), compared to the low population (Fig. 1C).